Drug Class: DPP-4 Inhibitor + Biguanide Antidiabetic Combination | Form: Extended-Release Oral Tablet | Prescription Status: Prescription Only (Rx) — DRAP Registered
What is Tagipmet XR 50/1000mg Tablet? Tagipmet XR 50/1000mg contains Sitagliptin 50mg and Metformin Hydrochloride 1000mg in an extended-release formulation — the higher Metformin strength combination for patients whose Type 2 diabetes requires more intensive glycaemic control than the 50/500mg combination provides. The 1000mg Metformin dose delivers stronger hepatic glucose production suppression and peripheral insulin sensitisation — approaching the maximum therapeutic Metformin dose where glycaemic efficacy is greatest. The XR formulation releases this higher Metformin dose gradually — maintaining the significantly improved gastrointestinal tolerability advantage of extended-release over immediate-release Metformin even at the higher 1000mg dose. This combination is typically the target maintenance dose for patients who have been successfully uptitrated from the 50/500mg starting combination.
What is Tagipmet XR 50/1000mg Used For?
- Type 2 diabetes — higher-dose combination therapy for patients inadequately controlled on 50/500mg (ذیابیطس ٹائپ 2 میں مضبوط بلڈ شوگر کنٹرول)
- Step-up from Tagipmet XR 50/500mg — uptitration when lower Metformin dose provides insufficient HbA1c reduction
- Established dual antidiabetic therapy — maintenance dose for patients stable on Sitagliptin plus high-dose Metformin
- Type 2 diabetes with significant insulin resistance — higher Metformin dose maximises insulin-sensitising benefit (انسولین مزاحمت میں زیادہ موثر علاج)
- Overweight and obese Type 2 diabetic patients — higher Metformin dose provides greater weight-neutral to modest weight-reducing benefit
- Simplifying regimen — replacing separate Sitagliptin 50mg and Metformin XR 1000mg tablets with single combination tablet
How Does it Work? Sitagliptin inhibits DPP-4 enzyme — maintaining elevated active GLP-1 and GIP incretin levels to stimulate glucose-dependent insulin secretion and suppress glucagon in a blood sugar-dependent manner — maintaining the low hypoglycaemia safety profile. Metformin 1000mg delivers its maximum clinically effective hepatic action — strongly inhibiting gluconeogenesis and glycogenolysis in the liver to significantly reduce fasting blood glucose, the primary driver of elevated HbA1c in Type 2 diabetes. At 1000mg Metformin also produces its strongest peripheral insulin sensitisation in muscle and fat tissue and greatest reduction in intestinal glucose absorption. The XR mechanism releases this 1000mg dose gradually over several hours — achieving equivalent glycaemic efficacy to immediate-release 1000mg Metformin with substantially better gastrointestinal tolerability throughout long-term treatment.
Dosage and Administration
⚠️ Swallow whole — never crush, break, or chew the extended-release tablet. Take with evening meal for best tolerability and absorption. Temporarily stop before any surgical procedure or iodinated contrast imaging — lactic acidosis risk. Monitor kidney function regularly — Metformin 1000mg contraindicated in significant kidney impairment. Never exceed total daily Metformin 2000mg from all sources.
| Indication | Usual Adult Dose | Frequency | Notes |
|---|---|---|---|
| Step-up from 50/500mg combination | 50mg/1000mg | Once or twice daily with meals | Uptitrated by diabetologist |
| Established maintenance therapy | 50mg/1000mg | Twice daily with meals | Standard target maintenance dose |
| Replacing separate tablets | 50mg/1000mg | Twice daily with meals | Equivalent to separate 50mg + 1000mg tablets |
| High insulin resistance | 50mg/1000mg | Twice daily with meals | Maximum Metformin benefit at this dose |
Active Ingredients
| Ingredient | Strength |
|---|---|
| Sitagliptin Phosphate Monohydrate | 50mg (as Sitagliptin) |
| Metformin Hydrochloride | 1000mg (Extended-Release) |
Who Should NOT Take Tagipmet XR 50/1000mg?
- Allergy to Sitagliptin, Metformin, or any component of the tablet
- Type 1 diabetes mellitus — not indicated
- Diabetic ketoacidosis — requires urgent insulin therapy
- Moderate to severe kidney impairment — GFR below 45ml/min; Metformin 1000mg strictly contraindicated
- Severe liver impairment — lactic acidosis risk with Metformin
- Acute conditions causing dehydration or tissue hypoxia — heart failure, respiratory failure, recent heart attack, sepsis
- History of pancreatitis — Sitagliptin associated with pancreatitis risk
- Alcohol dependence — greatly increases lactic acidosis risk
- Planned iodinated contrast imaging — stop Tagipmet XR before procedure
- Pregnancy and breastfeeding — insulin preferred
- Children under 18 years
Side Effects
Common: Mild nausea, mild stomach discomfort, mild diarrhoea — significantly reduced by XR formulation even at this higher 1000mg Metformin dose; taking with evening meal further minimises gastrointestinal effects. Mild headache, mild metallic taste, mild upper respiratory symptoms — generally well tolerated with the extended-release mechanism.
Serious — Stop and seek emergency help immediately: Lactic acidosis — rare but potentially fatal Metformin complication at higher doses; severe muscle pain, difficulty breathing, severe stomach pain, extreme weakness, feeling cold, dizziness, and slow or irregular heartbeat (فوری ہسپتال جائیں — یہ طبی ہنگامی صورتحال ہے — دیر نہ کریں), acute pancreatitis — severe persistent upper abdominal pain radiating to back with nausea and vomiting (پیٹ میں شدید درد — فوری مدد لیں), severe allergic reaction — sudden swelling of face or throat with difficulty breathing (فوری ہسپتال جائیں), Stevens-Johnson syndrome — widespread blistering and peeling skin (فوری مدد لیں), significant disabling joint pain (جوڑوں کا شدید درد — ڈاکٹر کو بتائیں), heart failure worsening with breathlessness and ankle swelling (فوری مدد لیں), hypoglycaemia when combined with sulphonylurea or insulin (بلڈ شوگر کا گرنا — فوری میٹھا کھائیں).
Drug Interactions
| Medicine | Interaction |
|---|---|
| Iodinated contrast media | Metformin must be stopped minimum 48 hours before contrast procedure — lactic acidosis risk is amplified at 1000mg dose; restart only after kidney function confirmed normal |
| Sulphonylureas (Glibenclamide, Glimepiride) | Significantly increased hypoglycaemia risk — sulphonylurea dose reduction required |
| Insulin | Increased hypoglycaemia risk — insulin dose careful adjustment under specialist supervision |
| Alcohol (شراب) | Significantly increases lactic acidosis risk — amplified at higher Metformin dose; avoid completely |
| Corticosteroids (Prednisolone) | Significantly raise blood glucose — monitor blood sugar very closely during corticosteroid courses |
| Diuretics (Furosemide, Thiazides) | Dehydration increases lactic acidosis risk — monitor kidney function and hydration status closely |
| ACE inhibitors / ARBs | May cause acute kidney impairment — reduced renal clearance increases Metformin 1000mg accumulation risk significantly |
| Cimetidine | Significantly increases Metformin blood levels — lactic acidosis risk amplified at higher dose |
| Beta-blockers | Mask hypoglycaemia warning signs — important when combined with sulphonylurea or insulin |
| Topiramate / Carbonic anhydrase inhibitors | Increased lactic acidosis risk with Metformin — avoid combination |
Storage: Store below 25°C in a cool, dry place. Protect from moisture and direct sunlight. Swallow whole — never break, crush, or chew. Keep out of reach of children (بچوں کی پہنچ سے دور رکھیں). Do not use after expiry date.
FAQs
Q: What is the difference between Tagipmet XR 50/500mg and Tagipmet XR 50/1000mg? Both contain Sitagliptin 50mg — the difference is solely in the Metformin dose. The 500mg combination is the starting dose allowing gradual Metformin uptitration. The 1000mg combination is the standard target maintenance dose delivering maximum Metformin glycaemic benefit — patients typically start at 50/500mg and uptitrate to 50/1000mg over several weeks once gastrointestinal tolerability is confirmed.
Q: Why is kidney function monitoring especially important at the higher 1000mg Metformin dose? Higher Metformin doses accumulate more significantly when kidney clearance is reduced — even mild deterioration in kidney function that might be acceptable with 500mg Metformin can lead to dangerous accumulation at 1000mg. Regular kidney function monitoring allows your diabetologist to detect early decline and reduce or stop Metformin before lactic acidosis risk becomes clinically significant.
Q: Can Tagipmet XR 50/1000mg be taken once daily instead of twice daily? Some patients take the full daily dose as a single once-daily tablet — however splitting into twice-daily dosing with meals generally provides better blood sugar control throughout the day and further reduces gastrointestinal side effects by spreading the 1000mg Metformin dose across two smaller administrations. Always follow your diabetologist's specific dosing schedule recommendation.
Medical Disclaimer: This information is for general awareness only and does not replace medical advice. Always consult a qualified doctor or pharmacist before taking any prescription medicine.